Related Experiment Video

Updated: Oct 4, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

The clinical impact of macrolide resistance in pneumococcal respiratory infections

J Garau1

  • 1Department of Medicina Interna, Hospital Mutua de Terrassa, University of Barcelona, C/san Antonio 8-14, 08221-Tarrasa, Barcelona, Spain. jgarau@retemail.es

International Journal of Antimicrobial Agents
|September 28, 2001
PubMed

Insights

Antibiotic resistance in bacteria is a growing concern, especially for respiratory tract infections. Physicians must consider local resistance patterns when choosing antibiotics for effective treatment.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antibiotic resistance has been reported since the 1960s and has significantly increased in recent years.
  • Respiratory tract infections account for a substantial portion of antibiotic use in both adults and children.
  • Streptococcus pneumoniae is a primary cause of community-acquired pneumonia and a common pathogen in respiratory infections.

Purpose of the Study:

  • To highlight the growing problem of antibiotic resistance in respiratory tract infections.
  • To emphasize the clinical implications of increasing bacterial resistance.
  • To inform clinical decision-making regarding antibiotic selection for respiratory infections.

Main Methods:

  • Review of published reports on antibiotic resistance trends.
  • Analysis of antibiotic usage patterns in respiratory tract infections.
  • Discussion of clinical implications and treatment considerations.

Main Results:

  • Antibiotic resistance has escalated, posing a significant challenge in treating bacterial infections.
  • High rates of antibiotic use for respiratory tract infections are linked to resistance concerns.
  • Increasing resistance levels necessitate careful consideration of local susceptibility data.

Conclusions:

  • Physicians must integrate local antibiotic susceptibility data into treatment decisions.
  • Pharmacokinetic and pharmacodynamic properties of antibiotics are crucial for selection.
  • Effective management of bacterial respiratory infections requires awareness of evolving resistance patterns.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: